Funding for this research was provided by:
Universitätsmedizin Greifswald
Article History
Accepted: 15 May 2023
First Online: 9 October 2023
Declarations
:
: O. Dziemba received project funding and travel support for congress trips from the company Cochlear. S. Merz is managing director of the company Merz Medizintechnik (Reutlingen). T. Hocke is an employee of the company Cochlear Deutschland GmbH & Co. KG. (Hanover). There are no more competing interests.
: For this article, the authors did not perform any studies on humans or animals. This retrospective data evaluation was positively decided by the ethics committee at the University Medical Center Greifswald (BB 173/21).
: The supplement containing this article is not sponsored by industry.